Ricki Louise Fairley - Mar 27, 2023 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role: Director
Signature: /s/ Beth Hecht as Attorney-in-Fact
Stock symbol: XERS
Transactions as of: Mar 27, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/29/2023, 04:23 PM
Next filing: Jun 5, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney